Biosimilars

Manufacturer Solutions

Helping your newest products thrive

AmerisourceBergen’s integrated commercialization and distribution services help biosimilar manufacturers realize the potential of this new and unique class of therapy. Our collaborative experts can help you devise channel strategies and select tailored solutions that overcome barriers to access and uptake.

Reaching patients where they are

Our extensive reach into health systems, physician practices, pharmacies and alternate sites of care makes your product accessible to patients and providers throughout the healthcare continuum. And our best-in-class distribution network ensures that your product reaches the right patients at the right time.
Our relationships span:
95%
U.S. HOSPITALS
65K+
SPECIALTY PHYSICIAN PRACTICES
34%
U.S. RETAIL PHARMACIES

Specialty physician GPO contracting

Connect with thousands of prescribers through our market-leading specialty and oncology GPOs, which comprise a collective purchasing power that is unrivaled in the industry. Members benefit from a versatile contract portfolio, clinically integrated specialty pharmacy services, practice management education and advocacy programs. Our integrated model tightens the provider-patient relationship and allows providers to more effectively guide treatment for better patient outcomes.

Improving product performance through targeted communication

Raise awareness of your newest product offerings through our CustomConnect℠ multi-channel marketing programs. CustomConnect seamlessly integrates your product message into customers' workflows so your communication stands out and gets recognized.

Enhancing the patient experience

Navigating a serious health condition can be frustrating for any patient. Lash Group, part of AmerisourceBergen, offers support services that consistently and compassionately help patients overcome obstacles related to access, affordability and engagement—resulting in better treatment outcomes.

International commercialization capabilities

Innomar Strategies, part of AmerisourceBergen, offers a range of integrated services for commercializing biosimilars in Canada. From market access consulting to patient support programs and distribution services, our experienced teams deliver customized, scalable solutions to successfully launch your product in the Canadian market.

Patient bedside care
Expert perspectives

Are biosimilars the new generics?

Dave Picard, Senior Vice President, Global Generic Pharmaceuticals at AmerisourceBergen, speaks with Becker's Hospital Review about the current state of the industry and upcoming trends for this new class of therapy.
Read the article

Get in touch

Our integrated portfolio of solutions and decades of industry experience make us the right partner for your product's successful journey to commercialization. Start a conversation with us to see how we can provide the strategies you need for optimal product performance. 
Contact AmerisourceBergen